Zobrazeno 1 - 10
of 231
pro vyhledávání: '"céline Bourgier"'
Autor:
Jessica Prunaretty, Laura Lopez, Morgane Cabaillé, Céline Bourgier, Aurélie Morel, David Azria, Pascal Fenoglietto
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeTo evaluate the feasibility to use a standard Ethos planning template to treat left-sided breast cancer with regional lymph nodes.Material/MethodsThe tuning cohort of 5 patients was used to create a planning template. The validation cohort inc
Externí odkaz:
https://doaj.org/article/d90480f1e50b435bbd69389daa154ba6
Autor:
Arthur Galand, Jessica Prunaretty, Nicolas Mir, Aurélie Morel, Céline Bourgier, Norbert Aillères, David Azria, Pascal Fenoglietto
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeThe aim of this study was to assess the feasibility of online adaptive radiotherapy with Ethos for breast cancer.Materials and methodsThis retrospective study included 20 breast cancer patients previously treated with TrueBeam. All had undergo
Externí odkaz:
https://doaj.org/article/3f68bb2260984c329417af4ffcddf7f9
Autor:
Stanislas Quesada, Pascal Fenoglietto, Sophie Gourgou, Claire Lemanski, Roxana Draghici, Norbert Ailleres, Jessica Prunaretty, David Azria, Céline Bourgier
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeVolumetric Modulated Arc Therapy (VMAT) exhibits potent advantages regarding target volume coverage and protection of organs at risk, notably in the context of anatomical constraints. Nevertheless, reports concerning VMAT for the treatment of
Externí odkaz:
https://doaj.org/article/6a40880478794462a019250039d0b0ca
Autor:
Jérôme Lacombe, Muriel Brengues, Alain Mangé, Céline Bourgier, Sophie Gourgou, André Pèlegrin, Mahmut Ozsahin, Jérôme Solassol, David Azria
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been published on this topic. Conversely, proteomics ap
Externí odkaz:
https://doaj.org/article/6467dd72a28346129ffe48e7196fef29
Autor:
Alexandre Thibault Jacques Maria, Léo Partouche, Radjiv Goulabchand, Sophie Rivière, Pauline Rozier, Céline Bourgier, Alain Le Quellec, Jacques Morel, Danièle Noël, Philippe Guilpain
Publikováno v:
Frontiers in Immunology, Vol 9 (2019)
Systemic sclerosis (SSc) is an autoimmune connective tissue disorder, characterized by multisystem involvement, vasculopathy, and fibrosis. An increased risk of malignancy is observed in SSc (including breast and lung cancers), and in a subgroup of p
Externí odkaz:
https://doaj.org/article/586c3a65eaca4280b33d3016ff1f27c4
Autor:
David Azria, Olivier Riou, Florence Castan, Tan Dat Nguyen, Karine Peignaux, Claire Lemanski, Jean-Léon Lagrange, Youlia Kirova, Eric Lartigau, Yazid Belkacemi, Céline Bourgier, Sofia Rivera, Georges Noël, Sébastien Clippe, Françoise Mornex, Christophe Hennequin, Andrew Kramar, Sophie Gourgou, André Pèlegrin, Pascal Fenoglietto, Esat Mahmut Ozsahin
Publikováno v:
EBioMedicine, Vol 2, Iss 12, Pp 1965-1973 (2015)
Background: Monocentric cohorts suggested that radiation-induced CD8 T-lymphocyte apoptosis (RILA) can predict late toxicity after curative intent radiotherapy (RT). We assessed the role of RILA as a predictor of breast fibrosis (bf+) after adjuvant
Externí odkaz:
https://doaj.org/article/998b692f296349d7954dcffe6dcf535a
Autor:
Alicia Le Bras, Yazid Belkacemi, céline Bourgier, Isabelle Gabelle-Flandin, Adeline Petit, Philippe Guilbert, Julien Geffrelot, Christian Carrie, Eleonor RIVIN DEL CAMPO, Chantal Hanzen, claire charra-brunaud, Guillaume Auzac, Thomas Lacornerie, Jérôme Lemonnier, Eric Lartigau, Isabelle Durand-Zaleski
Publikováno v:
Cancer Research. 83:P1-10
Purpose: The economic evaluation reports the incremental cost utility ratio and budget impact of APBI vs standard external beam WBI for the treatment of post-menopausal women with early stage breast cancer. Methods and materials: We compared 488 wome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8b0830df58c785b32d9c75bacc0dcc2
https://doi.org/10.1158/1538-7445.sabcs22-p1-10-13
https://doi.org/10.1158/1538-7445.sabcs22-p1-10-13
Autor:
Yazid Belkacemi, Isabelle Gabelle-Flandin, Marie-Cécile Le Deley, Adeline Petit, Philippe Guilbert, Julien Geffrelot, Christian Carrie, Eleonor Rivin Del Campo, Chantal Hanzen, Claire Charra-Brunaud, Isabelle Lecouillard, Nicolas Magne, Agnès Tallet, Nicolas Leduc, Blaha Belgadi, Philippe Fourneret, Alexandre Coutte, Esther Capelo, Franck Darloy, Muriel Garcia Ramirez, Philippe Dudouet, Pierre Clavere, Jean-Philippe Suchaud, Guillaume Auzac, Thomas Lacornerie, Jérôme Lemonnier, Céline Bourgier, Eric Lartigau
Publikováno v:
Cancer Research. 83:PD3-05
Purpose: The aim of current analyses is to report toxicity and cosmetic outcomes at 3 and up to 9 years of follow-up of post-menopausal patients randomized to receive either standard external beam whole breast radiotherapy (WBI), including hypofracti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::506483c8e0c00c2404a946a7e4bba76e
https://doi.org/10.1158/1538-7445.sabcs22-pd3-05
https://doi.org/10.1158/1538-7445.sabcs22-pd3-05
Autor:
Thomas Sarrade, Rodrigue Allodji, Youssef Ghannam, Guillaume Auzac, Sibille Everhard, Ophélie Querel, Youlia Kirova, Karine Peignaux, Philippe Guilbert, Claire Charra-Brunaud, Julien Blanchecotte, Rezart Belshi, David Pasquier, Séverine Racadot, Céline Bourgier, Sandrine Ducornet, David Gibon, Fabrice André, Florent De Vathaire, Sofia Rivera
Publikováno v:
Cancer Research. 82:P3-19
Purpose: In this paper, we describe the methodology used, and provide a first characterization of the study population and radiotherapy (RT) data in CANTO-RT (CANcer TOxicities Radiotherapy), the largest available multicenter prospective cohort of ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcf1f9207c193770c906016f4e5178d4
https://doi.org/10.1158/1538-7445.sabcs21-p3-19-01
https://doi.org/10.1158/1538-7445.sabcs21-p3-19-01
Autor:
Youssef Ghannam, Antonio Di Meglio, Thomas Sarrade, Alexandra Jacquet, Sibille Everhard, Youlia Kirova, Karine Peigneaux, Philippe Guilbert, Claire Chara-Brunaud, Julien Blanchecotte, Gilles Crehange, David Pasquier, Séverine Racadot, Céline Bourgier, Julien Geffrelot, Ahmed Benyoucef, Francois Paris, Guillaume Auzac, Inès Vaz-Luis, Sofia Rivera
Publikováno v:
Cancer Research. 82:P4-11
Background Fatigue is a common and disabling symptom experienced by patients (pts) after breast cancer (BC) treatment, significantly impacting their quality of life. However, this complex and multidimensional symptom often remains poorly managed. Pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81cfa7bc282fb5618702813349169c44
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-07
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-07